Stock overview
Abbvie Inc.
Explore the company, reported ownership, price history, and available source evidence.
AbbVie develops pharmaceuticals in immunology, oncology, neuroscience, aesthetics, and specialty medicine.
- Last close
- $264.34
- · ABBV
- Tracked holders
- 2 funds
- Latest available 13F per fund
ABBV · USD
Price
$264.34
+$45.80
(+20.96%)
over selected range
Close · Sep 25, 2026
Market closed
252 stored daily closes
$264.34
Sep 25, 2026
- Range low
- $197.38
- Range high
- $265.97
- Observations
- 252
- Session date
- Sep 25, 2026
Sep 25, 2025–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +10% 26'Q2 | $27,395,292 | 0.06% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+6% 26'Q2 | $479,381 | 0.01% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market